202 related articles for article (PubMed ID: 25704671)
1. Sulindac has strong antifibrotic effects by suppressing STAT3-related miR-21.
Zhou X; Li YJ; Gao SY; Wang XZ; Wang PY; Yan YF; Xie SY; Lv CJ
J Cell Mol Med; 2015 May; 19(5):1103-13. PubMed ID: 25704671
[TBL] [Abstract][Full Text] [Related]
2. Arsenic trioxide prevents rat pulmonary fibrosis via miR-98 overexpression.
Gao SY; Zhou X; Li YJ; Liu WL; Wang PY; Pang M; Xie SY; Lv CJ
Life Sci; 2014 Sep; 114(1):20-8. PubMed ID: 25123535
[TBL] [Abstract][Full Text] [Related]
3. Tanshinone IIA ameliorates bleomycin-induced pulmonary fibrosis and inhibits transforming growth factor-beta-β-dependent epithelial to mesenchymal transition.
Tang H; He H; Ji H; Gao L; Mao J; Liu J; Lin H; Wu T
J Surg Res; 2015 Jul; 197(1):167-75. PubMed ID: 25911951
[TBL] [Abstract][Full Text] [Related]
4. High-Mobility Group Box 1 Mediates Epithelial-to-Mesenchymal Transition in Pulmonary Fibrosis Involving Transforming Growth Factor-β1/Smad2/3 Signaling.
Li LC; Li DL; Xu L; Mo XT; Cui WH; Zhao P; Zhou WC; Gao J; Li J
J Pharmacol Exp Ther; 2015 Sep; 354(3):302-9. PubMed ID: 26126535
[TBL] [Abstract][Full Text] [Related]
5. Total polysaccharide of Yupingfeng protects against bleomycin-induced pulmonary fibrosis via inhibiting transforming growth factor-β1-mediated type I collagen abnormal deposition in rats.
Xu L; Li LC; Zhao P; Qi LW; Li P; Gao J; Fei GH
J Pharm Pharmacol; 2014 Dec; 66(12):1786-95. PubMed ID: 25209833
[TBL] [Abstract][Full Text] [Related]
6. Paeoniflorin suppresses TGF-β mediated epithelial-mesenchymal transition in pulmonary fibrosis through a Smad-dependent pathway.
Ji Y; Dou YN; Zhao QW; Zhang JZ; Yang Y; Wang T; Xia YF; Dai Y; Wei ZF
Acta Pharmacol Sin; 2016 Jun; 37(6):794-804. PubMed ID: 27133302
[TBL] [Abstract][Full Text] [Related]
7. Phenylbutyric acid inhibits epithelial-mesenchymal transition during bleomycin-induced lung fibrosis.
Zhao H; Qin HY; Cao LF; Chen YH; Tan ZX; Zhang C; Xu DX
Toxicol Lett; 2015 Jan; 232(1):213-20. PubMed ID: 25455454
[TBL] [Abstract][Full Text] [Related]
8. Protective roles of pulmonary rehabilitation mixture in experimental pulmonary fibrosis in vitro and in vivo.
Zhang L; Ji YX; Jiang WL; Lv CJ
Braz J Med Biol Res; 2015 Jun; 48(6):545-52. PubMed ID: 25992646
[TBL] [Abstract][Full Text] [Related]
9. Regulation of Transforming Growth Factor-β/Smad-mediated Epithelial-Mesenchymal Transition by Celastrol Provides Protection against Bleomycin-induced Pulmonary Fibrosis.
Divya T; Velavan B; Sudhandiran G
Basic Clin Pharmacol Toxicol; 2018 Aug; 123(2):122-129. PubMed ID: 29394529
[TBL] [Abstract][Full Text] [Related]
10. Hydrogen inhalation attenuated bleomycin-induced pulmonary fibrosis by inhibiting transforming growth factor-β1 and relevant oxidative stress and epithelial-to-mesenchymal transition.
Gao L; Jiang D; Geng J; Dong R; Dai H
Exp Physiol; 2019 Dec; 104(12):1942-1951. PubMed ID: 31535412
[TBL] [Abstract][Full Text] [Related]
11. Soluble epoxide hydrolase inhibitor AUDA decreases bleomycin-induced pulmonary toxicity in mice by inhibiting the p38/Smad3 pathways.
Dong XW; Jia YL; Ge LT; Jiang B; Jiang JX; Shen J; Jin YC; Guan Y; Sun Y; Xie QM
Toxicology; 2017 Aug; 389():31-41. PubMed ID: 28694203
[TBL] [Abstract][Full Text] [Related]
12. Low-dose paclitaxel ameliorates pulmonary fibrosis by suppressing TGF-β1/Smad3 pathway via miR-140 upregulation.
Wang C; Song X; Li Y; Han F; Gao S; Wang X; Xie S; Lv C
PLoS One; 2013; 8(8):e70725. PubMed ID: 23967091
[TBL] [Abstract][Full Text] [Related]
13. Protective Effect of Atazanavir Sulphate Against Pulmonary Fibrosis In Vivo and In Vitro.
Song S; Ji Y; Zhang G; Zhang X; Li B; Li D; Jiang W
Basic Clin Pharmacol Toxicol; 2018 Feb; 122(2):199-207. PubMed ID: 28816009
[TBL] [Abstract][Full Text] [Related]
14. [Effect of signal transducer and activator of transcription 1 antisense oligodeoxynucleotides on inflammatory mediators, type I and type III collagen mRNA of rat pulmonary fibrosis].
Wang WJ; Zeng M; Liu D; Fan XM; Zhu C; Zhan XQ
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2009 May; 25(5):389-92. PubMed ID: 19426591
[TBL] [Abstract][Full Text] [Related]
15. [Effects of andrographolide on the concentration of cytokines in BALF and the expressions of type I and III collagen mRNA in lung tissue in bleomycin-induced rat pulmonary fibrosis].
Zhu HL; Huang CL; Wang WJ; Zhan XQ; Fan XM
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Jul; 27(7):725-9. PubMed ID: 21722520
[TBL] [Abstract][Full Text] [Related]
16. Calcitriol inhibits bleomycin-induced early pulmonary inflammatory response and epithelial-mesenchymal transition in mice.
Tan ZX; Chen YH; Xu S; Qin HY; Zhang C; Zhao H; Xu DX
Toxicol Lett; 2016 Jan; 240(1):161-71. PubMed ID: 26520185
[TBL] [Abstract][Full Text] [Related]
17. Evaluating the inhibitory potential of sulindac against the bleomycin-induced pulmonary fibrosis in wistar rats.
Verma R; Brahmankar M; Kushwah L; Suresh B
Environ Toxicol Pharmacol; 2013 Nov; 36(3):769-78. PubMed ID: 23958969
[TBL] [Abstract][Full Text] [Related]
18. Tauroursodeoxycholic acid alleviates pulmonary endoplasmic reticulum stress and epithelial-mesenchymal transition in bleomycin-induced lung fibrosis.
Tong B; Fu L; Hu B; Zhang ZC; Tan ZX; Li SR; Chen YH; Zhang C; Wang H; Xu DX; Zhao H
BMC Pulm Med; 2021 May; 21(1):149. PubMed ID: 33952237
[TBL] [Abstract][Full Text] [Related]
19. [Effects of Notch-1/Twist-1 axis in the process of epithelial-mesenchymal transition of type II alveolar epithelial cell and its mechanism].
Tang J; Ke J; Fu Y; He XW; Li XW
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2021 Nov; 37(6):577-583. PubMed ID: 34821087
[No Abstract] [Full Text] [Related]
20. Total glycosides of Yupingfeng protects against bleomycin-induced pulmonary fibrosis in rats associated with reduced high mobility group box 1 activation and epithelial-mesenchymal transition.
Cui W; Li L; Li D; Mo X; Zhou W; Zhang Z; Xu L; Zhao P; Qi L; Li P; Gao J
Inflamm Res; 2015 Dec; 64(12):953-61. PubMed ID: 26411348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
